Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00686634
What this trial is testing

Sitagliptin in Combination With Metformin and Sulfonylurea

Who this might be right for
Type 2 Diabetes Mellitus
Charles Drew University of Medicine and Science 108
Testing effectiveness (Phase 2)UnknownNCT04268563
What this trial is testing

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Who this might be right for
Polycystic Ovary SyndromeInfertilityART
Shahid Beheshti University of Medical Sciences 80
Large-scale testing (Phase 3)Study completedNCT07076056
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2

Who this might be right for
Type 2 Diabetes
Daewon Pharmaceutical Co., Ltd. 230
Post-approval studies (Phase 4)Study completedNCT00820573
What this trial is testing

Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM

Who this might be right for
Diabetes
The University of Texas Health Science Center at San Antonio 16
Large-scale testing (Phase 3)Study completedNCT00813995
What this trial is testing

Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 395
Post-approval studies (Phase 4)Study completedNCT01907854
What this trial is testing

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 407
Post-approval studies (Phase 4)Study completedNCT02025907
What this trial is testing

Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 218
Post-approval studies (Phase 4)Study completedNCT06759922
What this trial is testing

Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Bahria University 172
Post-approval studies (Phase 4)WithdrawnNCT02250794
What this trial is testing

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit

Who this might be right for
Type 2 Diabetes Mellitus
Rush University Medical Center
Post-approval studies (Phase 4)Study completedNCT01890629
What this trial is testing

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

Who this might be right for
Type 2 Diabetes Mellitus
LG Life Sciences 69
Not applicableUnknownNCT06147518
What this trial is testing

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

Who this might be right for
Compensated CirrhosisDecompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 240
Large-scale testing (Phase 3)Study completedNCT00700817
What this trial is testing

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 665
Large-scale testing (Phase 3)Study completedNCT01602003
What this trial is testing

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
LG Life Sciences 425
Early research (Phase 1)Study completedNCT05549583
What this trial is testing

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Who this might be right for
BioequivalenceType 2 Diabetes
Galenicum Health 26
Not applicableStudy completedNCT01065766
What this trial is testing

Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 4,065
Post-approval studies (Phase 4)Study completedNCT01099618
What this trial is testing

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment

Who this might be right for
Ketosis Prone DiabetesDiabetes KetoacidosisHyperglycemia
Dawn Smiley MD 48
Large-scale testing (Phase 3)Study completedNCT00734474
What this trial is testing

LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 1,202
Large-scale testing (Phase 3)WithdrawnNCT01455909
What this trial is testing

Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Intarcia Therapeutics
Large-scale testing (Phase 3)Study completedNCT00545584
What this trial is testing

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 1,512
Testing effectiveness (Phase 2)Study completedNCT01059825
What this trial is testing

Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 375
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation